45
Growth Score
pts
Heat Score
-19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
231564
Terumo BCT develops and provides blood component and cellular technologies.
- Mani Venkatesh: Vice President of Digital Transformation
- Veerle d’Haenens: Head of the Global Therapy Innovations business unitsPast Role: Terumo BCT, General Manager Therapeutic Systems
About the Company
As a global leader in blood component, therapeutic apheresis and cellular technologies, They believe in the potential of blood to do even more for patients than it does today.
This belief inspires their innovation and strengthens their collaboration with customers.
Working together with their customers, they can make safer, higher-quality
transfusions available to more people. They can bring even more treatment options to patients through advanced blood therapies. And they can make the dream of new, cutting-edge blood and cell therapies the new standard of care. Their work has the potential to fundamentally improve health care.
Women Founded
